Dámaso Molero
Algemeen Directeur bij 3P Biopharmaceuticals SL
Profiel
Dámaso Molero is currently the Chief Executive Officer at 3P Biopharmaceuticals SL.
Previously, he held positions as Principal at Shionogi & Co., Ltd., Syntex, Inc., Glaxo, Inc., and Roche & Genentech, Inc. He obtained his undergraduate degree and MBA from the University of Navarra.
Actieve functies van Dámaso Molero
| Bedrijven | Functie | Begin |
|---|---|---|
3P Biopharmaceuticals SL
 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Algemeen Directeur | 01-04-2007 |
Eerdere bekende functies van Dámaso Molero
| Bedrijven | Functie | Einde |
|---|---|---|
| SHIONOGI & CO., LTD. | Corporate Officer/Principal | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
| Syntex, Inc. | Corporate Officer/Principal | - |
| Glaxo, Inc. | Corporate Officer/Principal | - |
Opleiding van Dámaso Molero
| University of Navarra | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| SHIONOGI & CO., LTD. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Health Technology |
| Glaxo, Inc. | |
| Syntex, Inc. | Miscellaneous |
